Une entrevue avec Dr. Jean-Pierre Routy: Écrire sur le cancer de la prostate pour «libérer la parole des hommes» ledevoir.com/lire/821686/ecr…
"We are delighted and honoured to welcome the CTN+ to the RI-MUHC. I am confident that this network will enhance Canada’s capacity to address HIV and STBBI from prevention to cure,” - Dr. Rhian Touyz, Executive Director and CSO, RI-MUHC.
tinyurl.com/mpbtxd7k
We are excited to introduce the next chapter in HIV and STBBI clinical trials research — the CTN+.
This renewed version of CTN, funded $25 million by the @CIHR_IRSC, is coordinated from the @RIMUHC1 and strengthened by regional hubs across the country.
hivnet.ubc.ca/news/2024/07/c…
Save the date of our Research Day. You can already register below. Notez la date, notre Journée de la recherche est le 30 avril prochain. Inscription ci-dessous.
idigh.ca/en/events/research-…
Congratulations Dr. Pai!
Félicitations à Madhukar Pai (@paimadhu), récemment nommé directeur du Département de santé mondiale et de santé publique de l'École de santé des populations et de santé mondiale de l'Université McGill! lnkd.in/eUTRiuGr
IDIGH retweeted
Congratulations to Drs. Sapha Barkati and Marina Klein for receiving the 2023 FMSQ prize for best research paper!
mcgill.ca/x/UEu
IDIGH retweeted
#CAHR2024 - Abstract submission now open!
#ACRV2024 - Appel à abrégés!
myemail.constantcontact.com/…
Interview with Marcel Behr about MUHC got talent: globalnews.ca/video/10019812…
IDIGH retweeted
Honoured to coauthor this article in Nature Reviews!
✅#Recompensation is a promising goal in patients with #NAFLD-related #cirrhosis.
👉nature.com/articles/s41575-0…
@mcgillu @cusm_muhc @CASLupdates @McGill_DOM @CNTRP @FRQS1 #WomenInMedicine @IDIGHProgram
Remember that the first objective in a patient with decompensated cirrhosis is achieving RECOMPENSATION.
This great article in @NatRevGastroHep reviews the mechanisms of recompensation in fatty liver.
@VirginiaHdezGea @GiadaSebastiani #livertwitter
dlvr.it/Sx2ngR
IDIGH retweeted
MI4 a le plaisir d'annoncer que l'inscription est maintenant ouverte pour notre 5ème symposium scientifique annuel!
-
MI4 is delighted to announce that registration is now open for our 5th Annual Scientific Symposium!
event.fourwaves.com/mi4sympo…
Help Dr. Behr to raise funds at this year MUHC's got talent. More details and performance preview:
talent.muhcfoundation.com/en
IDIGH retweeted
I have the opportunity to discuss the @PALACE_Trial #PENFAST during this @CSACI_ca webinar focused on #penicillinallergy - please join this accredited meeting tomorrow evening - Sept. 28 @ 7:30 PM EDT @CodeVie_Life @cusm_muh @McGill_DOM @AllergyMuhc
canadiansocietyofallergyandc…
IDIGH retweeted
Currently reading Guest Blog: The two-year journey of a patient–researcher and CTN postdoctoral fellow;url=hivnet.ubc.ca/news/2023/08/t…
Exciting news! Dr. Madhu Pai @paimadhu has been appointed as the inaugural Chair of the Department of Global and Public Health (DGPH), School of Population and Global Health (SPGH), Faculty of Medicine and Health Sciences (FMHS), #McGill University, effective Oct 1.
Our IDIDH Trainee Seminar Series launched successfully, fostering an engaging atmosphere for knowledge sharing.
Lauren Khoury, from the Netchiporouk lab, presented her latest findings on inflammatory skin disorders
Thank you to all who attended, whether in person or virtually.
The IDIGH Program will resume its seminar series on September 7 with career highlights of Nicole Bernard. More info:
idigh.ca/webinars/nicole-ber…
Nos séminaires seront de retour dès le 7 septemble! Nicole Bernard ouvrira le bal en présentant les découvertes phares de sa carrière.
IDIGH retweeted
Thank you for sharing our research! This can have an impact on #penicillin #allergy worldwide @PALACE_Trial
Clinical trail helps those with penicillin allergy. montreal.citynews.ca/2023/07…
IDIGH retweeted
Are you passionate about research in infectious diseases and microbial threats to human health? Join the MI4 team and help guide us into our new chapter!
Details about the Co-Director posting can be found here: mcgill.ca/mi4/files/mi4/2023…
Nous avons maintenant une page LinkedIn, suivez-nous!
linkedin.com/company/idighpr…
We now have a LinkedIn page.
IDIGH retweeted
Intravenous Liposomal Amphotericin B Efficacy and Safety for Cutaneous and Mucosal Leishmaniasis: A Systematic Review and Meta-analysis academic.oup.com/ofid/articl…



























